<qa>  What is the RISK of INTRALESIONAL EXCISION IN LENTIRELEVANCE OF IMIQUIMOD AS NEO-ADJUVANT TREATMENT TO REDUCE EXCISION SIZE AND THE RISK OF INTRALESIONAL EXCISION IN LENTIGO MALIGNANT OF THE FACE: 